MUC16 and neoplasm: When expression of PODO447 was compared to expression of CA125, MSLN and FOLRA (three of the most common tumor antigens currently used or under development for targeted therapies in HGSOC), only the PODO447 epitope showed a tight, inverse correlation with immune infiltration of T cells and B lineage cells.